{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:44:59Z","timestamp":1793994299921,"version":"4.8.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.505029\/2020-00"],"award-info":[{"award-number":["88887.505029\/2020-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["312211\/2021-0"],"award-info":[{"award-number":["312211\/2021-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/26686-2"],"award-info":[{"award-number":["2019\/26686-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The chemical classes of semicarbazones, thiosemicarbazones, and hydrazones are present in various compounds, each demonstrating diverse biological activities. Extensive studies have revealed their potential as schistosomicidal agents. Thiosemicarbazones, in particular, have shown inhibitory effects on\n                    <jats:italic>Schistosoma mansoni's<\/jats:italic>\n                    cathepsin B1 enzyme (\n                    <jats:italic>Sm<\/jats:italic>\n                    CB1), which plays a crucial role in hemoglobin degradation within the worm's gut and its nutrition processes. Consequently,\n                    <jats:italic>Sm<\/jats:italic>\n                    CB1 has emerged as a promising target for novel schistosomiasis therapies. Moreover, chloroquinoline exhibits characteristics in its aromatic structure that hold promise for developing\n                    <jats:italic>Sm<\/jats:italic>\n                    CB1 inhibitors, along with its interaction with hemoglobin's heme group, potentially synergizing against the parasite's gut. In this context, we report the synthesis of 22 hybrid analogs combining hydrazones and quinolines, evaluated against\n                    <jats:italic>S. mansoni<\/jats:italic>\n                    . Five of these hybrids demonstrated schistosomicidal activity in vitro, with GPQF-8Q10 being the most effective, causing worm mortality within 24 h at a concentration of 25 \u00b5M. GPQF-8Q8 proved to be the most promising in vivo, significantly reducing egg presence in feces (by 52.8%) and immature eggs in intestines (by 45.8%). These compounds exhibited low cytotoxicity in Vero cells and an in in vivo animal model (\n                    <jats:italic>Caenorhabditis elegans<\/jats:italic>\n                    ), indicating a favorable selectivity index. This suggests their potential for the development of new schistosomiasis therapies. Further studies are needed to uncover specific target mechanisms, but these findings offer a promising starting point.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-46959-3","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T06:01:44Z","timestamp":1699855304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Targeting the Schistosoma mansoni nutritional mechanisms to design new antischistosomal compounds"],"prefix":"10.1038","volume":"13","author":[{"given":"Tha\u00eds F. A.","family":"Pavani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Cirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thain\u00e1 R.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josu\u00e9","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela G. G.","family":"Rando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"46959_CR1","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1128\/AAC.01900-13","volume":"58","author":"EDF Santiago","year":"2014","unstructured":"Santiago, E. D. F. et al. Evaluation of the anti-Schistosoma mansoni activity of thiosemicarbazones and thiazoles. Antimicrob. Agents Chemother. 58, 352\u2013363 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"46959_CR2","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1128\/AAC.04601-14","volume":"59","author":"NC Fonseca","year":"2015","unstructured":"Fonseca, N. C. et al. Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1. Antimicrob. Agents Chemother. 59, 2666\u20132677 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"46959_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.molbiopara.2005.06.007","volume":"143","author":"JM Correnti","year":"2005","unstructured":"Correnti, J. M., Brindley, P. J. & Pearce, E. J. Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth. Mol. Biochem. Parasitol. 143, 209\u2013215 (2005).","journal-title":"Mol. Biochem. Parasitol."},{"key":"46959_CR4","doi-asserted-by":"publisher","first-page":"5231","DOI":"10.1021\/jm400282d","volume":"56","author":"AP Gorka","year":"2013","unstructured":"Gorka, A. P., de Dios, A. & Roepe, P. D. Quinoline drug-heme interactions and implications for antimalarial cytostatic versus cytocidal activities. J. Med. Chem. 56, 5231\u20135246 (2013).","journal-title":"J. Med. Chem."},{"key":"46959_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003856","volume":"10","author":"S Liu","year":"2014","unstructured":"Liu, S. et al. Expression profile of the Schistosoma japonicum degradome reveals differential protease expression patterns and potential anti-schistosomal intervention targets. PLoS Comput. Biol. 10, e1003856 (2014).","journal-title":"PLoS Comput. Biol."},{"key":"46959_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/jat.3357","volume":"37","author":"PR Hunt","year":"2017","unstructured":"Hunt, P. R. & The, C. Elegans model in toxicity testing. J. Appl. Toxicol. 37, 50\u201359 (2017).","journal-title":"J. Appl. Toxicol."},{"key":"46959_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.chemosphere.2019.01.021","volume":"221","author":"T Wu","year":"2019","unstructured":"Wu, T., Xu, H., Liang, X. & Tang, M. Caenorhabditis elegans as a complete model organism for biosafety assessments of nanoparticles. Chemosphere 221, 708\u2013726 (2019).","journal-title":"Chemosphere"},{"key":"46959_CR8","doi-asserted-by":"publisher","first-page":"116607","DOI":"10.1016\/j.jep.2023.116607","volume":"313","author":"DS de Costa","year":"2023","unstructured":"de Costa, D. S. et al. Antiparasitic properties of 4-nerolidylcatechol from Pothomorphe umbellata (L.) Miq. (Piperaceae) in vitro and in mice models with either prepatent or patent Schistosoma mansoni infections. J. Ethnopharmacol. 313, 116607 (2023).","journal-title":"J. Ethnopharmacol."},{"key":"46959_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2217\/nnm-2022-0228","volume":"18","author":"RL de Souza","year":"2023","unstructured":"de Souza, R. L. et al. Enhancing the antischistosomal activity of carvacryl acetate using nanoemulsion. Nanomedicine 18, 331\u2013342 (2023).","journal-title":"Nanomedicine"},{"key":"46959_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.exppara.2016.10.009","volume":"171","author":"LMR Antinarelli","year":"2016","unstructured":"Antinarelli, L. M. R. et al. Aminoquinoline compounds: Effect of 7-chloro-4-quinolinylhydrazone derivatives against Leishmania amazonensis. Exp. Parasitol. 171, 10\u201316 (2016).","journal-title":"Exp. Parasitol."},{"key":"46959_CR11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/jhet.3791","volume":"57","author":"HR Bhat","year":"2020","unstructured":"Bhat, H. R., Masih, A., Shakya, A., Ghosh, S. K. & Singh, U. P. Design, synthesis, anticancer, antibacterial, and antifungal evaluation of 4-aminoquinoline-1,3,5-triazine derivatives. J. Heterocycl. Chem. 57, 390\u2013399 (2020).","journal-title":"J. Heterocycl. Chem."},{"key":"46959_CR12","first-page":"928","volume":"16","author":"J Kalita","year":"2020","unstructured":"Kalita, J., Chetia, D. & Rudrapal, M. Design, synthesis, antimalarial activity and docking study of 7-chloro-4-(2-(substituted benzylidene)hydrazineyl)quinolines. Med. Chem. (Los. Angeles) 16, 928\u2013937 (2020).","journal-title":"Med. Chem. (Los. Angeles)"},{"key":"46959_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.13171\/mjc.1.3.2011.26.09.22","volume":"1","author":"ES Coimbra","year":"2011","unstructured":"Coimbra, E. S. et al. Amodiaquine analogs. Synthesis and anti-leishmanial activity. Mediterr. J. Chem. 1, 106\u2013113 (2011).","journal-title":"Mediterr. J. Chem."},{"key":"46959_CR14","doi-asserted-by":"publisher","first-page":"6272","DOI":"10.1016\/j.bmcl.2009.09.098","volume":"19","author":"ALP Cand\u00e9a","year":"2009","unstructured":"Cand\u00e9a, A. L. P. et al. Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives. Bioorgan. Med. Chem. Lett. 19, 6272\u20136274 (2009).","journal-title":"Bioorgan. Med. Chem. Lett."},{"key":"46959_CR15","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1007\/s00044-011-9894-8","volume":"21","author":"RC Montenegro","year":"2012","unstructured":"Montenegro, R. C. et al. 1-(7-Chloroquinolin-4-yl)-2-[(1H-pyrrol-2-yl)methylene]hydrazine: A potent compound against cancer. Med. Chem. Res. 21, 3615\u20133619 (2012).","journal-title":"Med. Chem. Res."},{"key":"46959_CR16","doi-asserted-by":"publisher","first-page":"19320","DOI":"10.1038\/s41598-022-23110-2","volume":"12","author":"JR Brito","year":"2022","unstructured":"Brito, J. R. et al. Neolignans isolated from Saururus cernuus L. (Saururaceae) exhibit efficacy against Schistosoma mansoni. Sci. Rep. 12, 19320 (2022).","journal-title":"Sci. Rep."},{"key":"46959_CR17","doi-asserted-by":"crossref","unstructured":"Silva, T. C. et al. N-(4-Methoxyphenyl)pentanamide, a simplified derivative of albendazole, displays anthelmintic properties against the nematode Toxocara canis. Microbiol. Spectr. 10, 13 (2022).","DOI":"10.1128\/spectrum.01807-22"},{"key":"46959_CR18","first-page":"1","volume":"11","author":"T Stiernagle","year":"2006","unstructured":"Stiernagle, T. Maintenance of C. elegans. WormBook 11, 1\u201311 (2006).","journal-title":"WormBook"},{"key":"46959_CR19","doi-asserted-by":"publisher","first-page":"6648","DOI":"10.1128\/AAC.01371-15","volume":"59","author":"J de Moraes","year":"2015","unstructured":"de Moraes, J., Dario, B. S., Couto, R. A. A., Pinto, P. L. S. & da Costa Ferreira, A. M. Antischistosomal activity of oxindolimine-metal complexes. Antimicrob. Agents Chemother. 59, 6648\u20136652 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"46959_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ebiom.2019.04.029","volume":"43","author":"EM Lago","year":"2019","unstructured":"Lago, E. M. et al. Phenotypic screening of nonsteroidal anti-inflammatory drugs identified mefenamic acid as a drug for the treatment of schistosomiasis. EBioMedicine 43, 370\u2013379 (2019).","journal-title":"EBioMedicine"},{"key":"46959_CR21","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1021\/acs.jnatprod.0c01050","volume":"83","author":"DP Sessa","year":"2020","unstructured":"Sessa, D. P. et al. 15\u03b2-Senecioyl-oxy- ent -kaur-16-en-19-oic acid, a diterpene isolated from Baccharis lateralis, as promising oral compound for the treatment of schistosomiasis. J. Nat. Prod. 83, 3744\u20133750 (2020).","journal-title":"J. Nat. Prod."},{"key":"46959_CR22","doi-asserted-by":"crossref","unstructured":"de Brito, M. G. et al. Therapeutic effect of diminazene aceturate on parasitic blood fluke Schistosoma mansoni infection. Antimicrob. Agents Chemother. 64, 33 (2020).","DOI":"10.1128\/AAC.01372-20"},{"key":"46959_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph14070686","volume":"14","author":"R Porto","year":"2021","unstructured":"Porto, R. et al. Antiparasitic properties of cardiovascular agents against human intravascular parasite Schistosoma mansoni. Pharmaceuticals 14, 1\u201315 (2021).","journal-title":"Pharmaceuticals"},{"key":"46959_CR24","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1021\/acs.jnatprod.1c00153","volume":"84","author":"A Dematei","year":"2021","unstructured":"Dematei, A. et al. Mechanistic insights into the leishmanicidal and bactericidal activities of batroxicidin, a cathelicidin-related peptide from a South American Viper (Bothrops atrox). J. Nat. Prod. 84, 1787\u20131798 (2021).","journal-title":"J. Nat. Prod."},{"key":"46959_CR25","doi-asserted-by":"publisher","first-page":"23437","DOI":"10.1038\/s41598-021-02792-0","volume":"11","author":"CS Morais","year":"2021","unstructured":"Morais, C. S. et al. Pyrazoline derivatives as promising novel antischistosomal agents. Sci. Rep. 11, 23437 (2021).","journal-title":"Sci. Rep."},{"key":"46959_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13071-020-04140-z","volume":"13","author":"RP Xavier","year":"2020","unstructured":"Xavier, R. P. et al. H1-antihistamines as antischistosomal drugs: in vitro and in vivo studies. Parasit. Vectors 13, 278 (2020).","journal-title":"Parasit. Vectors"},{"key":"46959_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113387","volume":"264","author":"MP Silva","year":"2021","unstructured":"Silva, M. P. et al. Brazilian red propolis exhibits antiparasitic properties in vitro and reduces worm burden and egg production in an mouse model harboring either early or chronic Schistosoma mansoni infection. J. Ethnopharmacol. 264, 113387 (2021).","journal-title":"J. Ethnopharmacol."},{"key":"46959_CR28","doi-asserted-by":"publisher","unstructured":"Mengarda, A. C. et al. Antiparasitic activity of piplartine (piperlongumine) in a mouse model of schistosomiasis. Acta Trop. 105350 (2020). https:\/\/doi.org\/10.1016\/j.actatropica.2020.105350.","DOI":"10.1016\/j.actatropica.2020.105350"},{"key":"46959_CR29","doi-asserted-by":"crossref","unstructured":"Mengarda, A. C. et al. Licarin A, a neolignan isolated from Nectandra oppositifolia Nees & Mart. (Lauraceae), exhibited moderate preclinical efficacy against Schistosoma mansoni infection. Phyther. Res. 35, 5154\u20135162 (2021).","DOI":"10.1002\/ptr.7184"},{"key":"46959_CR30","doi-asserted-by":"crossref","unstructured":"Roquini, D. B. et al. Promethazine exhibits antiparasitic properties in vitro and reduces worm burden, egg production, hepatomegaly, and splenomegaly in a schistosomiasis animal model. Antimicrob. Agents Chemother. 63, 12 (2019).","DOI":"10.1128\/AAC.01208-19"},{"key":"46959_CR31","doi-asserted-by":"crossref","unstructured":"Guerra, R. A. et al. In vitro and in vivo studies of spironolactone as an antischistosomal drug capable of clinical repurposing. Antimicrob. Agents Chemother. 63, 1722 (2019).","DOI":"10.1128\/AAC.01722-18"},{"key":"46959_CR32","doi-asserted-by":"crossref","unstructured":"Xavier, E. S. et al. Therapeutic efficacy of carvacrol-loaded nanoemulsion in a mouse model of schistosomiasis. Front. Pharmacol. 13, 917363 (2022).","DOI":"10.3389\/fphar.2022.917363"},{"key":"46959_CR33","doi-asserted-by":"publisher","first-page":"40890","DOI":"10.1021\/acsomega.3c06111","volume":"8","author":"VC Rocha","year":"2023","unstructured":"Rocha, V. C. et al. Evaluating the antischistosomal activity of dehydrodieugenol B and its methyl ether isolated from Nectandra leucantha\u2014A preclinical study against Schistosoma mansoni infection. ACS Omega 8, 40890\u201340897 (2023).","journal-title":"ACS Omega"},{"key":"46959_CR34","doi-asserted-by":"crossref","unstructured":"Roquini, D. B. et al. Susceptibility of Angiostrongylus cantonensis larvae to anthelmintic drugs. Front. Pharmacol. 13, 901459 (2022).","DOI":"10.3389\/fphar.2022.901459"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46959-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46959-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46959-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T06:04:35Z","timestamp":1699855475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46959-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46959"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46959-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"assertion":[{"value":"27 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19735"}}